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1  | INTRODUC TION
Depressive disorders are an important clinical problem as they can 
decrease the quality of life of the patient and caregiver.1 Depressive 
disorders are associated with functional impairment, cognitive 
changes, and increased morbidity and mortality;2-4 unfortunately, 
their prevention and treatment remain a challenge. Despite the rel-
ative effectiveness of antidepressant medication and psychological 
treatment, major depression in older persons over longer follow- up 
periods shows a chronic remitting course or, in some patients, has a 
chronic character.4 This implies the need for alternative methods to 
treat depressive disorders in the elderly.
Sunlight has long been used to treat different medical conditions. 
For example, Niels Ryberg Finsen demonstrated that ultraviolet (UV) 
light can have a curative effect in lupus vulgaris (a skin variant of 
tuberculosis); in 1903, he was awarded the Noble Prize for Medicine 
and Physiology. Nowadays, UV light is an important treatment op-
tion for several skin diseases including psoriasis, atopic dermatitis, 
morphea, scleroderma, vitiligo, and mycosis fungoides.5 A mood- 
enhancing effect of UV light has also been reported.6-9 This effect 
might be accomplished via two target organs working as receptors 
for UV light: that is skin and eyes.
A possible mood- modulating effect of UV light via the skin is 
through the vitamin D pathway. The major source of vitamin D 
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Summary
Background: Human and animal studies have shown that exposure to ultraviolet light 
can incite a chain of endocrine, immunologic, and neurohumoral reactions that might 
affect mood. This review focuses on the evidence from clinical trials and observa-
tional studies on the effect of ultraviolet light on mood, depressive disorders, and 
well- being.
Methods: A search was made in PubMed, Embase, Web of Science, Cochrane, 
Psychinfo, CINAHL, Academic Search Premier and Science Direct, and the refer-
ences of key papers, for clinical trials and observational studies describing the effect 
of ultraviolet light applied to skin or eyes on mood, depressive disorders, and 
well- being.
Results: Of the seven studies eligible for this review, the effect of ultraviolet light on 
mood, depressive symptoms and seasonal affective disorders was positive in six of them.
Conclusions: Of the seven studies, six demonstrated benefit of exposure to ultravio-
let radiation and improvement in mood which supports a positive effect of ultraviolet 
light on mood. Because of the small number of the studies and their heterogeneity, 
more research is warranted to confirm and document this correlation.
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for humans is exposure of the skin to sunlight (UVB 280- 315 nm) 
resulting in the conversion of 7- dehydrocholesterol to previtamin 
D3. The recent discovery that the human brain also possesses 
vitamin D receptors10,11 indicates that mood and depressive dis-
orders might be influenced by vitamin D deficiency directly, by 
acting on brain cells.
Other pathways that may be triggered by UV light to modulate 
mood and act through skin exposure involve three local systems: 
(i) the skin analog of the hypothalamic- pituitary- adrenal (HPA) axis,12 
(ii) the serotoninergic/melatoninergic system,13 and (iii) the immune 
system.14,15 These pathways are assumed to interplay with systemic 
mechanisms of body homeostasis.14
Using eyes as a target, bright light therapy is applied for the 
treatment of seasonal affective disorders (SAD); it is thought that 
bright light can help to suppress melatonin production in the pineal 
gland, thereby attenuating many of the symptoms associated with 
SAD.16 However, it remains unclear whether UV light has an addi-
tional value in the therapeutic light spectrum, or whether it exercises 
only a deleterious effect on the eyes.
Bearing in mind the theoretical points mentioned above, this re-
view explores and summarizes the evidence obtained from clinical 
trials and observational studies on the effect of UV light applied to 
the skin or as a component of light therapy applied to the eyes on 
mood, depressive disorders, and well- being.
2  | METHODS
2.1 | Protocol and registration
This systematic review was designed according to the PRISMA 
method.17,18 The protocol is registered and published in the 
PROSPERO database (PROSPERO 2017: CRD42017059971).
2.2 | Eligibility criteria
A PICO (population, intervention, control, outcome)- based search 
strategy was conducted on 22 March 2017. Eligible for this review 
was studies in the general population in which: (i) exposure to UV 
light or sunlight was used as an intervention, and (ii) the effect on 
mood, depressive disorders, and well- being was measured as an 
outcome. Included were clinical trials and observational studies on 
sunlight, in which exposure to sunlight occurred outdoors and the 
number of exposure hours was recorded.
2.3 | Search strategy
With the assistance of an experienced librarian the following bib-
liographic databases were searched: PubMed, Embase, Web of 
Science, Cochrane, Psychinfo, CINAHL, Academic Search Premier 
and Science Direct. Also, the references of key papers and of the 
included studies were explored. The search strategy included terms 
related to UV light, mood, affective disorders, and well- being (for the 
PubMed search strategy see Appendix A). Although no restriction 
was made regarding the date of publication, articles had to be in 
English, Dutch, German or Russian.
2.4 | Study selection
Of the identified studies, the titles and abstracts were screened 
by the first author (BV) and categorized on exclusion criteria. The 
categories were reviewed by the second author (RvB) by randomly 
assessing the titles and abstracts in the different categories; dif-
ferences were discussed until consensus was reached. References 
from the included studies and from key articles were also assessed. 
The full- text articles derived from this process were independently 
assessed by the first and second author; any differences were dis-
cussed until consensus was reached.
2.5 | Data extraction
Information extracted from the selected studies included: year 
of publication, study design, study population (characteristics of 
chronic disease, if any), setting (community, or hospitalized), inter-
vention and control conditions, outcome measures on mood and 
results, and information for assessment of risk of bias. The first and 
second author extracted data from the studies independently from 
each other; any discrepancies were resolved by discussion.
2.6 | Risk of bias
Risk of bias of the individual studies was evaluated on outcome 
level by the first and second author independently, using Cochrane 
Collaboration’s tool for assessing risk of bias.19 Risk of bias as-
sessment comprised evaluation of sequence generation, alloca-
tion concealment, blinding of participants and outcome assessors, 
incomplete outcome data, selective outcome reporting, and other 
bias. Disagreements were resolved through discussion and consen-
sus, or by consulting the last author (MC).
2.7 | Data synthesis and analysis
All outcomes on mood, depressive disorders and well- being re-
ported in the studies were extracted. For each study, characteristics 
including study size, population, intervention, control group, main 
outcome measures, and follow- up period were described. Synthesis 
and analysis were performed in a narrative manner and structured 
according to the site of action of UV light: skin or eyes.
3  | RESULTS
3.1 | Study selection
After removing duplicates from the 702 articles yielded by the search, 
677 records remained (Figure 1). After screening on title (no UV light, 
sunshine, mood, mood disorders or well- being) and language, 532 
publications were excluded and 145 publications remained. After 
     |  3VELEVA Et AL.
evaluating these 145 papers on abstract, another 126 were excluded 
for the following reasons: 9 were ideas, editorials or theoretical re-
views, 17 concerned vitamin D and depression but no intervention 
with UV light, 96 examined the effect of light therapy on depression 
but UV light was not used as a therapeutic fraction of light spectrum, 
and 4 explored the relation between vitamin D and sunlight but not 
in connection with mood, mood disorders, or well- being.
Following assessment of the remaining 19 full- text articles for el-
igibility, 12 studies were excluded: 3 RCTs that had no control group 
without UV light, 4 examined the effect of sunlight on mood on sub-
jects while staying indoors (no direct contact of ultraviolet light to skin 
or eyes), 4 did not measure mood variables but preference for UV light 
as the only psychological parameter, and 1 was a systematic review.
Finally, 7 studies were regarded eligible for this systematic re-
view. All examined the effect of UV light or sunlight on mood, well- 
being or depressive disorders, applied directly to skin or eyes as an 
intervention in a group of healthy people, or patients diagnosed with 
a chronic disease. In 6 of these 7 studies, a control group was used 
for comparison, and one of the studies was observational.
3.2 | Study characteristics
Seven studies were assessed in this review,5,16,20-24 ie 6 clinical trials 
of which 2 randomized controlled trials (RCTs), 2 cross- over studies, 
1 prospective clinical trial, 1 study with a randomized parallel design, 
and 1 observational study. The characteristics of these studies are 
presented in Table 1.
3.3 | Participants
Participants in the selected studies were healthy volunteers,22 and 
patients with fibromyalgia syndrome,20 dermatological conditions,5 
multiple sclerosis (MS),21 and SAD.16,23,24 The numbers of partici-
pants per study ranged from 1323 to 198.21
3.4 | Methods of selected studies
All studies included a control group, except the observational 
study.21 The control groups consisted of: (i) patients belonging to 
the same cohort but not receiving the intervention,20,22,24 (ii) two 
control groups of which one of the same cohort having the interven-
tion applied on a smaller surface of the body and one composed of 
healthy volunteers (receiving or not receiving the intervention),5 or 
(iii) the study had a cross- over design.16,24
All studies used a repeated measure design for evaluation of the 
effect of the intervention.
3.5 | Interventions
The studies can be categorized into two groups according to the tar-
get site of the intervention: in one group the targeted organ was the 
skin,5,20-22 whereas in the other the intervention was applied to the 
eyes (with the retina as target).16,23,24
The intervention used in the selected studies was UV light,5,20,22 
optical light combined with UV light (16,23,24 or outdoor exposure to 
sunlight.21 In five of the studies, UV light was explicitly defined as 
UVA light (315- 400 nm) 16,20,22-24 and in one study different groups 
were specifically receiving UVA, UVB (280- 315 nm) or UVA+UVB 
light.5
In the 4 studies in which skin was the target, UV light was applied 
either to the whole body,5,22 to smaller body areas,5 or was not spec-
ified.20 The duration of UV light exposure to the skin ranged from 
3- 6 weeks (2- 3 times a week for 10- 15 minutes). In the study with 
sun exposure, the duration of sun exposure was calculated in hours 
F IGURE  1 PRISMA- based flowchart of 
the literature search, selection, and  
review process
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spent in the sun during the weekends and holidays between summer 
2002 and summer 2005.21
Phototherapy in studies targeting the retina was applied for 1, 
2 or 3 weeks. Duration of the interventions per day was either 2 
sessions of 60 minutes in the morning and afternoon,16 or 1 session 
of 2 hours in the morning.23,24
3.6 | Outcome measures
This systematic review focuses on the outcome measures mood, 
depressive disorders, and well- being.
3.6.1 | Mood
Mood was assessed in two studies. In the study with patients with 
fibromyalgia, mood was evaluated with the PANAS (Positive and 
Negative Affect Scale).20 In the study with healthy volunteers, emo-
tional state and physical awareness were assessed with the BBS 
(Basler Befindlichkeits- Scala) and the FKB- 20 (Fragebogen zum 
Körperbild), respectively.22
3.6.2 | Depression
Depression was assessed in five studies. Depression was evaluated 
with the CPRS- S- A (Comprehensive Psychopathological Self- Rating 
Scale for Affective Syndromes) which had been transformed to cor-
respond to the MADRS (Montgomery- Asberg Depression Rating 
Scale) in patients with dermatological conditions and healthy volun-
teers as a control group.5
Depression symptoms and anxiety were measured with the 
HADS (Hospital Anxiety and Depression Scale) in patients with MS.21 
HDRS- SAD (Hamilton Depression Rating Scale- Seasonal Affective 
Disorders Version) and the BDI (Beck Depression Inventory) were 
used in all studies comparing phototherapy in the optical range, with 
phototherapy in the optical range enriched in UV light in patients 
with SAD.16,23,24
3.6.3 | Well- being
Although well- being was frequently mentioned in two studies,5,20 
none of these studies used a measurement scale specified for 
well- being.
3.7 | Risk of bias
The results of the risk of bias evaluation are summarized in Table 2; in 
some cases a narrative explanation is given for further clarification.
All studies gave little or no information on the sequence gener-
ation and allocation concealment. Significant bias was found in all 
studies as a consequence of study design. None of the studies met 
all the criteria of a double- blinded randomized control study with a 
good statistical power. Both studies by Lam et al23,24 had a low risk 
bias according to the Cochrane Collaboration’s tool of bias. However, T
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the first study had little power because of the small number of par-
ticipants and a possible order effect that can confound multiple 
cross- over designs;23 the second study raises questions about the 
compliance of patients who performed the intervention at home.24 
Although Knippenberg et al21 performed a study with long duration 
and many participants, the observational character of the study was 
a limiting factor. Gambichler et al22 mentioned that not blinding their 
participants may have influenced their results. Edstrom et al5 per-
formed a study creating groups with different UV light exposure, 
different spectrum of the UV light, and a two control group design, 
but with limited possibility to blind the participants and assessors 
because of the different interventions. Taylor et al20, apart from not 
blinding the assessors, provided no information on mood changes in 
the second (randomized control) phase of their study. These authors 
focused on improvement of mood after each UV session in the accli-
mation phase when each participant underwent 6 tanning sessions 
at which they were exposed to two beds: a non- UV control bed and a 
UV treatment bed, which might simply be a consequence of an order 
effect, determined by the preference for a UV bed.
3.8 | Results of individual studies
Results of the individual studies are presented in Table 1.
3.8.1 | Mood
Both studies using UV light targeted to skin and examining the psy-
chological parameters showed a significant improvement in mood. 
Gambichler et al22 concluded that UVA- exposed volunteers were 
more balanced, less nervous, more strengthened and robust, and 
more satisfied with their own appearance after 3 weekly sessions of 
whole body UVA exposure.
Taylor et al20 showed increased positive affect and decreased 
negative affect after UV stimuli in the acclimation phase of their 
study (6 sessions non- UV, followed by a UV bed) as measured by 
tanning preference, tanning expectations, increased well- being, 
relaxation, and decreased tension, stress and nervousness. The ad-
justed mean for the PANAS negative affect (10 low- 50 high) after UV 
exposure in patients with fibromyalgia was 13.5 (SE .84) compared 
to 13.8 (SE 1.00) after the control session (P = .019). The adjusted 
mean for the PANAS positive affect (10 low- 50 high) after UV expo-
sure was 29.3 (SE 1.84) compared to 28.3 (SE 1.75) after the control 
sessions (P = .030).
3.8.2 | Depression scores
Four of the 5 studies that investigated the effect of UV light re-
ported a positive effect of UV radiation on depression scores in the 
examined populations. Both studies that applied UV exposure to 
the skin reported positive effects,5,21 two studies that applied UV 
exposure to the eye reported positive effects,16,23 and one study 
that applied UV exposure to the eye reported no positive effect on 
depression.24
Edstrom et al5 demonstrated a significant improvement in 
MADRS in both dermatological patients and volunteers after 
6 weeks (2- 3 sessions weekly) UVB exposure of the whole body and 
significant improvement of MADRS in dermatologic patients who 
received whole body irradiation with UVA or combined UVA/UVB 
irradiation with the same duration. The median of the MADRS score 
in the group of the dermatological patients with whole body UV irra-
diation was 8 (IQR 4- 13) before the treatment, and 4 (IQR 2- 7) after 
the treatment. The median of the MADRS score in the group of the 
volunteers receiving whole body UV irradiation was 5 (IQR 4- 10) be-
fore the treatment, and 4 (IQR 0- 5) after the treatment. However, 
because a MADRS score below 20 is considered non- pathological, 
these data do not describe the effect of UV light on depression, but 
only on depressive scores. The authors stated that well- being im-
proved as the MADRS score decreased.
Knippenberg et al21 showed that higher levels of reported sun 
exposure were associated with lower depression scores in an ob-
servational cohort study of 198 MS patients with a follow- up of 
2.5 years. Of the 198 observed patients, 38 patients had the diag-
nosis depression. The association between sun exposure and HADS 
depression score in patients with MS was β	=	−.44	 (95%	 CI	 0.89,	
0.01, P = .056) with 1.5 hours/day sun exposure and β	=	−.79	(95%	CI	
−1.34,	−0.25,	P = .005) with 3.5 hours/day sun exposure.
Three studies examined the effect of phototherapy enriched in 
UVA light exposed to the eye on depressive episodes of patients 
with SAD. Two of these three studies concluded that maximum ef-
ficiency of phototherapy on depression was observed in the groups 
receiving combined optical and UVA light.16,23 In the first study, the 
UVA light condition was the only treatment in which the traditional 
measures of depression and the HAM- D scores (P < .003) and BDI 
scores (P < .02) were significantly reduced23 after 1- week treatment 
periods, one hour per day with different light spectrum and intensity. 
In the second study in week 3 and 4 of the treatment, the maximum 
efficiency of 4- week treatment two hours per day was observed 
in the group with combined optical and UVA radiation which was 
significant only with respect to HDRS- SAD (P = .03 and P = .01, re-
spectively), but not to the BDI score.16 The third study found that 
addition of UV light to the optical spectrum in the phototherapy was 
not beneficial to alleviation symptoms of SAD during 2- week light 
treatment.24
3.8.3 | Area exposed to UV light
One of the studies proposed that UV light exposure of the whole 
body (rather than one part of the body) may be superior in influenc-
ing mood in a positive manner;5 however, no other studies examined 
this aspect.
3.8.4 | Benefits of UV spectrum
In most of the studies, the fraction of UV light used was UVA light. 
In the study of Edstrom, however, it was shown that UVB light was 
superior to UVA light in improving depressive symptoms.5
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4  | DISCUSSION
4.1 | Main findings
After an extensive search in multiple bibliographic databases, 145 
papers were screened on title and abstract and 19 publications were 
assessed for eligibility. Of these publications, 7 met the inclusion cri-
teria and are discussed in this systematic review.
The selected studies with skin as the target organ for UV 
light 5,20-22 were relatively heterogeneous. There was diversity in 
the population examined, in the psychological instruments used to 
assess mood and depressive disorders, and in the spectrum of the 
UV light that was applied. Although mood and depressive symptoms 
were analyzed in all these studies, they were not always the primary 
outcome. Other outcomes of UV light treatment were also inves-
tigated, eg effect on pain, fatigue, and dermatological conditions. 
However, the effect of UV light on mood and depressive symptoms 
was consistently corrected for these other conditions.
The overall effect of UV light intervention on mood was positive 
in the two studies that examined this effect.20,22 However, the bias 
present in them made the results inconclusive.
None of the two studies using depression scales as a measurement 
for depressive symptoms conducted a separate analysis in a subgroup 
of depressed participants.5,21 The study population was a combination 
of people with depression, depressive symptoms and people without 
depression. Anyway both of them showed improvement of depressive 
scores after treatment with UV light or sunlight. In the study observ-
ing the effect of sun exposure on depressive symptoms in patients 
with MS two mechanisms are discussed as possibly involved in the im-
provement of the depressive scores: the immunologic and endocrine 
mechanisms of UV light and the effect of bright light.21
The trials targeting the retina with optical light enriched with the 
UV fraction were performed with a homogenous population of pa-
tients with SAD.16,23,24 The UV light used in the studies was UVA 
light fraction added to the optical range. The studies had depres-
sion as their main outcome and the psychological instruments used 
to measure depression were comparable. Despite the homogenous 
populations and the comparable instruments used, the effects of UV 
light on SAD were variable. Duration and intensity of the light treat-
ment in those studies was different and all of them had some degree 
of risk of bias.
4.2 | Strengths and limitations
For this review, an extensive search was made in major electronic 
databases and the references in key and selected articles were 
checked. All of the selected studies, apart from one that was ob-
servational,21 used a control group, assessed mood and depressive 
disorders with more than one psychological instrument, and per-
formed repeated measurements. The one observational study was 
of longer duration and had good statistical power. The effects in the 
observational study and the controlled studies (although relatively 
heterogeneous in character) concurred with each other.
Most RCTs had problems with allocation concealment and 
blinding. In the trials with UV light intervention affecting the skin, 
tanning can be a confounder and, if not blinded, can disturb the re-
sults. In one of the studies, the participants were blinded for the 
tanning and the lamps whereas the assessors were not.20
In one of the studies, the number of participants was too low to 
have any statistical power.23 In two of the studies, a per- protocol 
analysis was performed that could have influenced evaluation of the 
effect of the intervention;5,22 on the other hand, this may have pro-
vided a better picture of the effect of the treatment.
Finally, because of the small number of studies which met the 
inclusion criteria and the small amount of dispersion in the sample 
size, publication bias cannot be excluded.
4.3 | Comparison with other studies
Research on the beneficial effects of UV light on mood and depres-
sion is still in its infancy.25 The effect of UV light on skin as a target 
organ in improving mood and depressive disorders has not yet been 
examined by systematically reviewing the existing literature. To our 
knowledge this is the first review to focus on this effect. An interest-
ing prospective controlled study of Meffert et al26, not included in 
our review because a double intervention was used (UV and infra-
red (IR) light), reports on the effect of 10 low- dose UV and infrared 
(IR) irradiations of elderly people with inflammatory degenerative 
muscle and bone disease. Under controlled conditions, suberythe-
mal amounts of UV and IR resulted in some favorable and continual 
effects like increase in serum 25(OH) D level, decrease in pain, and 
improvement of well- being and training state. It may be useful to 
reproduce this study in separate groups with UV light and IR light 
only, and a control group.
To study the effect of UV light applied to the retina in the treat-
ment of SAD, Lee et al27 performed a meta- analysis on spectral 
properties of phototherapy in these disorders. They found no differ-
ence in the treatment efficacy between full spectrum light with UV 
component, full spectrum light without UV component, and green- 
yellow light in SAD. However, due to insufficient information on the 
search strategy and eligible articles, no meaningful conclusions can 
be drawn.
A possible mood- modulating effect of UV light via the skin is 
through the vitamin D pathway. Many observational studies found 
a significant negative correlation between 25(OH)D levels and de-
pression	 in	 people	 ≥60	years.28-33 In a recent meta- analysis, how-
ever, no evidence was found for a reductive effect of vitamin D 
supplementation on depression in adults.34
Similarly, a recent prospective observational study of 
Knippenberg et al21, included in our review, reported that sun expo-
sure, rather than 25(OH)D levels, was associated with fewer symp-
toms of depression and fatigue in patients with multiple sclerosis. 
The relation between vitamin D, UVB and mood is still not well 
understood and possibly not all beneficial effects of UV radiation 
exposure occur through UVB induced vitamin D synthesis,25 as we 
already discussed in the introduction.
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5  | CONCLUSIONS AND IMPLIC ATIONS
Of the 7 included studies, 6 showed a positive effect of UV light 
on mood, depressive scores or SAD which supports a positive cor-
relation between ultraviolet light exposure and mood improvement. 
However, the small number of studies, their heterogeneity and the 
small number of participants in some studies, the existing bias, and 
the suboptimal study designs make it difficult to draw general conclu-
sions about the effect of UV light on mood and depressive disorders.
Dating from ancient times, researchers have suggested that sun-
shine, apart from its deleterious effects, also has curative effects. 
Because of the seasonal and meteorological changes, we cannot use 
sunshine in an unlimited way. This has triggered research to deter-
mine the components in sunshine that may have a beneficial effect 
on health, as well as their artificial reproduction. The administration 
of bright white visible light is considered to be the treatment of choice 
for patients with SAD.35,36 We have concentrated on the UV com-
ponent of sunshine and its effect on mood and depressive disorders. 
The results of the reviewed studies, the available knowledge on UV 
light mechanisms, and the neural, endocrine and immune regulation of 
mood provide sufficient information to warrant further research in this 
area. First of all, appropriate UV exposure schedules need to be estab-
lished to predict and control DNA damage.37 Second, a good design of 
future studies (double- blind, RCTs with sufficient power) is required. In 
addition, studies in the general population, as well as in cohorts of peo-
ple with depressive disorders, are needed. Important aspects in this 
are a good definition and differentiation of the light spectrum, determi-
nation of the therapeutic range of the intervention, and the duration of 
the effect which can be ensured by repeated measurements.
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